With the growing landscape of incretin-based hormone therapies, we now have choice when it comes to prescribing these medications for the treatment of diabetes,” study lead author Liana K.

GLP-1 is an incretin hormone, an enterogasterone that plays a crucial role in regulating appetite and food intake by stimulating insulin secretion, inhibiting glucagon secretion, and delaying ...

Lexicon Pharmaceuticals (LXRX) announced that it has entered into an exclusive license agreement with Novo Nordisk (NVO) for LX9851, a first-in-class, oral non-incretin development candidate in ...

The rising prevalence of obesity has prompted the development of effective weight loss treatments. Several peptide hormones have a key role in appetite regulation and metabolism, but the discovery ...

These drugs mimic or enhance the effects of incretins, which are hormones that stimulate insulin release from the pancreas in response to meals. Through improving insulin secretion and reducing ...

The poll asked respondents about their knowledge of, and experience with, a range of weight management medications including bupropion-naltrexone, phentermine-topiramate and the incretin mimetics ...

The safety profile of UBT251 was consistent with incretin-based therapies. The most common adverse events were gastrointestinal and the vast majority were mild to moderate in severity. In the ...